Dr Jon Levine

Jon Levine is Professor of Medicine in the Divisions of Rheumatology and Clinical Pharmacology, and Experimental Therapeutics, as well as a member of the Graduate Program in Neuroscience and its Executive Committee at The University of California at San Francisco (UCSF). The areas of Dr. Levine’s research include elucidation of the transducers, second messenger systems and ionic channel mediating inflammatory, neuropathic, occupational musculoskeletal and generalized pain syndromes, the role of neuroimmune mechanisms in pain and inflammation, the mechanism of placebo analgesia, sex differences in pain, response to analgesic therapies and the inflammatory process, and basic mechanisms mediating diabetic- chemotherapy- HIV/AIDS therapy- and alcohol-induced painful neuropathy.

Professor Levine has done research on pain and analgesia for over 30 years and has been the recipient of several academic awards including: Young Investigator of the International Association of Pain, American Society for Clinical Investigation and Association of Academic Professors membership, Guest Investigator in the ARC Muscle Mechanisms Laboratory (Oxford University), Chancellor’s Commendation for Research Excellence (University of California, San Francisco), Hartford Foundation Fellow, Most Important New Research in Rheumatic Diseases (NIH Annual Report to Congress), Frederick J. Kerr award of the American Pain Society and Rita Allen Foundation Fellow. He has published over 400 basic science and clinical articles in this area, funded by the National Institutes of Health. He is listed in ISI World’s most cited authors (Top < 0.5%) and is in the 95th percentile of the distribution of extramural NIH grants over the last 25 years.

He received a BS in Biophysics and a MA in Bioengineering from the University of Michigan, a PhD in Neurobiology from Yale and an MD from The University of California at San Francisco. He then trained in Rheumatology and Clinical Immunology (under Jack Stobo) (UCSF), and Clinical Pharmacology and Experimental Therapeutics (under Henry Bourne) (UCSF).